CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+4.96%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.62B
AUM Growth
+$1.62B
(-6%)
Cap. Flow
-$206M
Cap. Flow
% of AUM
-12.77%
Top 10 Holdings %
Top 10 Hldgs %
61.42%
Holding
47
New
2
Increased
9
Reduced
7
Closed
13
Top Buys
| 1 |
Perrigo
PRGO
|
$59.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$52M |
| 3 |
Viatris
VTRS
|
$43.2M |
| 4 |
Gilead Sciences
GILD
|
$35.6M |
| 5 |
Tenet Healthcare
THC
|
$31.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$66.5M |
| 2 |
Cigna
CI
|
$64M |
| 3 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
$50.8M |
| 4 |
Cencora
COR
|
$49.6M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$44.8M |
Sector Composition
| 1 | Healthcare | 81.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $184M | 8.09% | 4,000,000 +1,130,000 | +39% | +$52M |
|
|
2
Viatris
VTRS
$12.3B
| $148M | 6.49% | 3,873,000 +1,133,000 | +41% | +$43.2M |
|
|
3
Perrigo
PRGO
$3.27B
| $112M | 4.93% | 1,213,600 +643,600 | +113% | +$59.4M |
|
|
4
Gilead Sciences
GILD
$140B
| $94.9M | 4.17% | 1,200,000 +450,000 | +60% | +$35.6M |
|
|
ENDP
5
DELISTED
Endo International plc
ENDP
| $85.4M | 3.76% | 4,240,000 -805,000 | -16% | -$16.2M |
|
6
Select Medical
SEM
$1.61B
| $81.3M | 3.58% | 6,025,000 +450,000 | +8% | +$6.08M |
|
|
MDCO
7
DELISTED
Medicines Co
MDCO
| $75.5M | 3.32% | 2,000,000 | – | – |
|
|
CSII
8
DELISTED
Cardiovascular Systems, Inc.
CSII
| $71.2M | 3.13% | 3,000,000 -1,100,000 | -27% | -$26.1M |
|
|
GHDX
9
DELISTED
Genomic Health, Inc.
GHDX
| $71.1M | 3.13% | 2,458,100 | – | – |
|
10
Brookdale Senior Living
BKD
$1.83B
| $69.8M | 3.07% | 4,000,000 | – | – |
|
11
Orthofix Medical
OFIX
$592M
| $64.2M | 2.82% | 1,500,000 | – | – |
|
12
LivaNova
LIVN
$3.08B
| $60.1M | 2.64% | 1,000,000 -200,000 | -17% | -$12M |
|
13
Community Health Systems
CYH
$387M
| $57.7M | 2.54% | 5,000,000 +1,550,000 | +45% | +$17.9M |
|
|
14
Tenet Healthcare
THC
$16.3B
| $56.7M | 2.49% | 2,500,000 +1,375,000 | +122% | +$31.2M |
|
15
Nektar Therapeutics
NKTR
$568M
| $55M | 2.42% | 3,200,000 -1,050,000 | -25% | -$18M |
|
|
UAM
16
DELISTED
Universal American Corp
UAM
| $44.9M | 1.98% | 5,875,000 | – | – |
|
17
Alkermes
ALKS
$4.78B
| $44.1M | 1.94% | 937,300 | – | – |
|
18
Bausch Health
BHC
$2.74B
| $31.2M | 1.37% | 1,271,500 -384,500 | -23% | -$9.44M |
|
19
CONMED
CNMD
$1.68B
| $30M | 1.32% | +750,000 | New | +$30M |
|
20
Option Care Health
OPCH
$4.65B
| $29.4M | 1.29% | 10,180,000 | – | – |
|
21
PTC Therapeutics
PTCT
$3.92B
| $28M | 1.23% | 2,000,000 +500,000 | +33% | +$7.01M |
|
|
NVTA
22
DELISTED
Invitae Corporation
NVTA
| $21.4M | 0.94% | 2,442,122 -304,500 | -11% | -$2.67M |
|
|
ARNA
23
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $18.4M | 0.81% | 10,500,000 | – | – |
|
|
ELOS
24
DELISTED
Syneron Medical Ltd
ELOS
| $16.8M | 0.74% | 2,347,593 | – | – |
|
|
AMAG
25
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $15M | 0.66% | 611,390 +11,390 | +2% | +$279K |
|